Nanoform, a drug enabling nanotechnology company, has named Dr Goncalo Rebelo de Andrade as its chief of Business Operations, it was reported yesterday.
The role integrates commercial and operational, and Dr Andrade will work closely with Christian Jones, recently appointed chief commercial officer, to manage operational activities for new projects. Dr Andrade will also co-ordinate company activities to deliver services to clients, according to the company.
Dr Andrade has come mostly from a business development, management and intellectual property background within pharmaceutical and biotech companies. He has held roles for Hovione Capital, a life science focused venture capital company, and has served on several life science company boards.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer